ColdZyme is the future of cold relief. By breaking the viral cycle at the first signs of symptoms, the product helps cut illness duration in half and speeds up recovery.

We offer a unique, evidence-based alternative in a market dominated by outdated products. ColdZyme reduces viral load by 94 percent, helping you avoid putting your life on hold.

My focus is to lead Enzymatica into its next phase of growth. ColdZyme is a consumer favorite with clinically proven efficacy – we have the potential to become a global leader.